David S Yee

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
    David S Yee
    Department of Urology and Chao Family Comprehensive Cancer Center, University of California at Irvine Orange, CA 92868, USA
    Mol Cancer 9:162. 2010
  2. doi Prognostic significance of lymphovascular invasion in radical prostatectomy specimens
    David S Yee
    Urology Service, Department of Surgery, Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 108:502-7. 2011
  3. doi Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience
    David S Yee
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Urology 75:1199-204. 2010
  4. pmc Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy
    Andrew H Feifer
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:3933-42. 2011
  5. ncbi Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection
    Darren J Katz
    Department of Surgery Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 106:391-6. 2010
  6. pmc Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis
    William T Lowrance
    Division of Urology, Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 118:3079-86. 2012
  7. pmc Locally advanced prostate cancer: a population-based study of treatment patterns
    William T Lowrance
    Department of Surgery, Division of Urology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
    BJU Int 109:1309-14. 2012
  8. doi Developments in the surgical management of sporadic synchronous bilateral renal tumours
    William T Lowrance
    Department of Surgery Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 105:1093-7. 2010
  9. pmc Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial
    David S Yee
    Urology Service, Department of Surgery, and Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 105:185-90. 2010
  10. doi Renal oncocytosis: management and clinical outcomes
    Ari Adamy
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 185:795-801. 2011

Detail Information

Publications18

  1. pmc The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
    David S Yee
    Department of Urology and Chao Family Comprehensive Cancer Center, University of California at Irvine Orange, CA 92868, USA
    Mol Cancer 9:162. 2010
    ..We investigated the effect and underlying mechanism of a naturally-occurring Wnt inhibitor, WIF1, on the growth and cellular invasiveness of a bone metastatic PCa cell line, PC3...
  2. doi Prognostic significance of lymphovascular invasion in radical prostatectomy specimens
    David S Yee
    Urology Service, Department of Surgery, Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 108:502-7. 2011
    ..Given that LVI may play a role in the metastatic process, it may be useful in clinical decision-making regarding adjuvant therapy for patients treated with RP...
  3. doi Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience
    David S Yee
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Urology 75:1199-204. 2010
    ..The extent of pelvic lymphadenectomy during radical prostatectomy has not been standardized. However, evidence demonstrates that an ePLND yields a greater number of positive nodes...
  4. pmc Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy
    Andrew H Feifer
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:3933-42. 2011
    ..The objectives of this study were to identify predictors of PLND and to assess the impact of surgical technique in a contemporary, population-based cohort...
  5. ncbi Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection
    Darren J Katz
    Department of Surgery Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 106:391-6. 2010
    ..To compare the perioperative outcomes of standard pelvic to full-template lymph node (LN) dissection (LND) during robotic-assisted laparoscopic prostatectomy (RALP)...
  6. pmc Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis
    William T Lowrance
    Division of Urology, Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 118:3079-86. 2012
    ..MRP with robotic assistance is generally more expensive than ORP, but it is not clear whether subsequent costs of care vary by approach...
  7. pmc Locally advanced prostate cancer: a population-based study of treatment patterns
    William T Lowrance
    Department of Surgery, Division of Urology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
    BJU Int 109:1309-14. 2012
    ..This study defines treatment patterns of locally advanced prostate cancer within the United States and identifies predicators of who receives multimodality therapy rather than monotherapy...
  8. doi Developments in the surgical management of sporadic synchronous bilateral renal tumours
    William T Lowrance
    Department of Surgery Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 105:1093-7. 2010
    ....
  9. pmc Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial
    David S Yee
    Urology Service, Department of Surgery, and Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 105:185-90. 2010
    ....
  10. doi Renal oncocytosis: management and clinical outcomes
    Ari Adamy
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 185:795-801. 2011
    ..We describe our experience with renal oncocytosis, focusing on management and outcomes...
  11. pmc Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer
    Ari Adamy
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 185:477-82. 2011
    ..We evaluated predictors of progression after starting active surveillance, especially the role of prostate specific antigen and immediate confirmatory prostate biopsy...
  12. doi Complications after radical and partial nephrectomy as a function of age
    William T Lowrance
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 183:1725-30. 2010
    ..We determined if the association of age and perioperative outcomes differed between nephrectomy types...
  13. pmc Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes
    William T Lowrance
    Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, and Health Outcomes Research Group, New York, New York, USA
    J Urol 183:1366-72. 2010
    ..We compared laparoscopic prostatectomy with or without robotic assistance vs open radical prostatectomy in terms of postoperative outcomes and subsequent cancer directed therapy...
  14. doi Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer
    David S Yee
    Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 183:1751-6. 2010
    ..We compared the outcomes of patients with bladder cancer previously treated for prostate cancer with radiotherapy vs other treatment modalities...
  15. pmc Fossa navicularis strictures due to 22F catheters used in robotic radical prostatectomy
    David S Yee
    University of California, Irvine Medical Center, 101 The City Drive, Irvine, CA 92868, USA
    JSLS 11:321-5. 2007
    ..We describe herein our experience to determine and prevent fossa navicularis stricture development...
  16. pmc Ethnic differences in bladder cancer survival
    David S Yee
    Department of Surgery, University of Utah, Salt Lake City, Utah, USA
    Urology 78:544-9. 2011
    ..Racial disparities in bladder cancer outcomes have been documented with poorer survival observed among blacks. Bladder cancer outcomes in other ethnic minority groups are less well described...
  17. pmc Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies
    William T Lowrance
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 105:16-20. 2010
    ....
  18. ncbi Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer
    David S Yee
    Department of Urology, University of California Irvine Medical Center, Orange, CA 92868, USA
    Arch Pathol Lab Med 131:902-8. 2007
    ..Although commonly underexpressed in prostate cancer, the association of reduced expression with pathologic grade and stage is unknown...